Summary

The remote patient monitoring market is projected to reach USD 66.33 billion by 2031 from USD 36.29 billion in 2026, at a high CAGR of 12.8% during the forecast period. The remote patient monitoring (RPM) market is experiencing rapid technological advancements driven by the integration of artificial intelligence (AI), wearable biosensors, cloud computing, the Internet of Things (IoT), and predictive analytics. Companies and research institutions are increasingly developing AI-enabled RPM platforms capable of continuous real-time health tracking, early risk detection, and personalized disease management. Additionally, on November 25, researchers developed a multimodal AI RPM framework using the HALO-X platform that achieved 83.9% accuracy in predicting adverse clinical events among cancer patients by integrating wearable sensor data, clinical records, and patient-reported outcomes (Source: arXiv). Such initiatives highlight the growth of the global remote patient monitoring market.

deployment is the fastest-growing segment in the remote patient monitoring software by deployment.”
Cloud-based deployment is expected to be the fastest-growing segment in the remote patient monitoring market, mainly because this model has several advantages, such as easy integration of data from multiple cloud sources, unlimited access by users from remote locations, low maintenance costs, high security and privacy, easy access, no need to buy hardware up front, and excellent flexibility in the use of capacity and resources. A plethora of applications made accessible through the cloud-based model, with core functionalities including accounting, performance management, and webmail and instant messaging, are proving helpful in fueling this particular portion.
“North America dominated the remote patient monitoring market in 25.”
The remote patient monitoring market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The North American region dominated the remote patient monitoring market due to several factors, including high adoption rates of healthcare technologies, a robust, well-established healthcare infrastructure, and sustained growth in healthcare spending that supports this progress. Additionally, North America is home to several leading digital health and wearable technology innovators. Companies such as BioIntelliSense are expanding continuous remote monitoring solutions using wearable biosensor platforms for acute and post-acute care. Similarly, Oura Health is expanding smart ring-based cardiovascular and wellness monitoring capabilities across the US market.
The breakdown of primary participants is as mentioned below:
? By Company Type - Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
? By Designation - C-level: 35%, Director-level: 40%, and Others: 25%
? By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.
Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Healthcare, Inc. (Japan), GE Healthcare (US), Oracle (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany), Baxter (US), Biobeat (Israel), Biotronik (Germany), VitalConnect (US), and others are the key players in the remote patient monitoring market.
? The study includes an in-depth competitive analysis of these key players in the remote patient monitoring market, with their company profiles, recent developments, and key market strategies.

Research Coverage
The report analyzes the remote patient monitoring market. It aims to estimate the market size and future growth potential of various market segments based on indication, component, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, offerings, recent developments, and key market strategies.
Reasons to buy this report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the remote patient monitoring market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
? Analysis of key drivers (transformation of patient care through digital innovation, Expansion of telehealth in remote patient monitoring), restraints (high investments and lack of IT expertise, behavioral barriers and healthcare affordability challenges in remote patient monitoring) opportunities (emergence of AI & ML, growing shift toward outpatient care environments, gradual shift toward outpatient care environments), and challenges (concerns associated with data security, data accessibility issues) influencing the growth of the remote patient monitoring market
? Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the remote patient monitoring market
? Market Development: Comprehensive information about lucrative markets?the report analyzes the remote patient monitoring market across varied regions.
? Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the remote patient monitoring market
? Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), and Siemens Healthineers AG); among others in the remote patient monitoring market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 36
1.1 STUDY OBJECTIVES 36
1.2 MARKET DEFINITION 36
1.3 MARKET SCOPE 37
1.3.1 MARKET SEGMENTATION 37
1.3.2 INCLUSIONS & EXCLUSIONS 38
1.3.3 YEARS CONSIDERED 39
1.3.4 CURRENCY CONSIDERED 39
1.4 LIMITATIONS 40
1.5 STAKEHOLDERS 40
1.6 SUMMARY OF CHANGES 40
2 EXECUTIVE SUMMARY 42
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 42
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 43
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 44
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 45
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 46
3 PREMIUM INSIGHTS 47
3.1 REMOTE PATIENT MONITORING MARKET OVERVIEW 47
3.2 REMOTE PATIENT MONITORING MARKET, BY COMPONENT & REGION 48
3.3 REMOTE PATIENT MONITORING MARKET: REGIONAL SNAPSHOT 48
4 MARKET OVERVIEW 49
4.1 INTRODUCTION 49
4.1.1 DRIVERS 50
4.1.1.1 Transformation of patient care through digital innovation 50
4.1.1.2 Expansion of telehealth in remote patient monitoring 51
4.1.1.3 Rising prevalence of chronic diseases 52
4.1.1.4 Increasing geriatric population and rising uptake of RPM services 53
4.1.1.5 Growing need for cost-containment across healthcare facilities 54
4.1.1.6 Technological innovation in wearables, mHealth apps, and connected devices 55
4.1.2 RESTRAINTS 56
4.1.2.1 High investments and lack of IT expertise 56
4.1.2.2 Behavioral barriers and healthcare affordability challenges in remote patient monitoring 57
4.1.2.3 Challenges associated with CMS regulations 57
?
4.1.3 OPPORTUNITIES 58
4.1.3.1 Emergence of AI & ML 58
4.1.3.2 Gradual shift toward outpatient care environments 59
4.1.3.3 Increasing utilization for infectious disease diagnostics 60
4.1.3.4 Rising initiatives for hospital-at-home programs 61
4.1.4 CHALLENGES 61
4.1.4.1 Concerns associated with data security 61
4.1.4.2 Data accessibility issues 63
4.1.4.3 Incorporation of SDOH factors into RPM programs 64
4.2 UNMET NEEDS AND WHITE SPACES 64
4.3 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 65
4.4 STRATEGIC MOVES BY TIER 1/2/3 65
5 INDUSTRY TRENDS 66
5.1 PORTER’S FIVE FORCES ANALYSIS 66
5.1.1 THREAT OF NEW ENTRANTS 67
5.1.2 THREAT OF SUBSTITUTES 67
5.1.3 BARGAINING POWER OF SUPPLIERS 67
5.1.4 BARGAINING POWER OF BUYERS 68
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 68
5.1.6 GRADUAL SHIFT TO VALUE-BASED & PATIENT-CENTRIC CARE 68
5.2 MACROECONOMIC INDICATORS 68
5.2.1 INTRODUCTION 68
5.2.2 GDP TRENDS AND FORECAST 69
5.2.3 TRENDS IN GLOBAL HEALTHCARE 69
5.3 ECOSYSTEM ANALYSIS 69
5.4 VALUE CHAIN ANALYSIS 70
5.5 PRICING ANALYSIS 71
5.5.1 INDICATIVE PRICING FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER (2025) 72
5.5.2 INDICATIVE PRICE FOR REMOTE PATIENT MONITORING BY REGION (2025) 73
5.6 TARIFF & REGULATORY ANALYSIS 73
5.6.1 TARIFF DATA (HS CODE 9018) 73
5.6.2 TARIFF DATA (HS CODE 9021) 74
5.6.3 TARIFF DATA (HS CODE 9022) 75
5.7 TRADE ANALYSIS 76
5.7.1 TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 90189099) 76
5.7.2 TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 9021) 77
5.7.3 TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 9022) 78
?
5.8 KEY CONFERENCES AND EVENTS, 2026?2027 79
5.8.1 REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2026?2027 79
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 80
5.10 CASE STUDY ANALYSIS 80
5.10.1 REMOTE PATIENT MONITORING PORTAL AUTOMATION 80
5.10.1.1 Case 1: Cost savings and performance boost through automation 80
5.10.2 PATIENT MONITORING PORTAL AUTOMATION 81
5.10.2.1 Case 2: RPM drives engagement and generates substantial returns 81
5.11 IMPACT OF 2025 US TARIFF ? REMOTE PATIENT MONITORING MARKET 82
5.11.1 INTRODUCTION 82
5.11.2 KEY TARIFF RATES 82
5.11.3 PRICE IMPACT ANALYSIS 83
5.11.4 IMPACT ON COUNTRY/REGION 83
5.11.4.1 US 83
5.11.4.2 Europe 83
5.11.4.3 Asia-Pacific 84
5.11.5 IMPACT ON END USERS 84
5.11.5.1 Healthcare Providers 84
5.11.5.2 Healthcare Payers 84
5.11.5.3 Patients 84
5.11.5.4 Pharmaceutical & Biotechnological Companies 84
5.11.5.5 Medtech Companies 85
5.11.5.6 Other End Users 85
5.12 TECHNOLOGY ANALYSIS 85
5.12.1 KEY EMERGING TECHNOLOGIES 85
5.12.1.1 Miniature wearable devices 85
5.12.1.2 Artificial intelligence & machine learning 85
5.12.1.3 Cloud computing 86
5.12.1.4 Patient engagement tools 86
5.12.1.5 EHR integration 86
5.12.1.6 Voice assistant integration 86
5.12.2 COMPLEMENTARY TECHNOLOGIES 87
5.12.2.1 5G connectivity 87
5.12.2.2 mHealth apps 87
5.12.2.3 Digital therapeutics 87
5.12.2.4 Telehealth platforms 87
5.12.3 ADJACENT TECHNOLOGIES 88
5.12.3.1 POC diagnostics 88
5.12.3.2 Smart home health devices 88
5.13 TECHNOLOGY/PRODUCT ROADMAP 88
?
5.14 PATENT ANALYSIS 89
5.14.1 PATENT PUBLICATION TRENDS FOR REMOTE PATIENT MONITORING 89
5.14.2 JURISDICTION AND TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING 89
5.14.3 LEADING PATENTS IN REMOTE PATIENT MONITORING MARKET 91
5.15 FUTURE APPLICATIONS 91
5.16 IMPACT OF GENERATIVE AI/AI ON REMOTE PATIENT MONITORING MARKET 92
5.16.1 KEY USE CASES 93
5.16.2 CASE STUDIES FOR GENERATIVE AI/AI IMPLEMENTATION 94
5.16.2.1 Case study 1: Enhancing remote patient monitoring for cancer treatment with NLP and HIPAA-compliant annotation 94
5.16.2.2 Case study 2: Leveraging AI for proactive infection prevention in hospitals 95
5.16.2.3 Telehealth & telemedicine 96
5.16.2.4 Wearable devices 96
5.16.2.5 Digital healthcare 97
5.16.2.6 Home healthcare 97
5.16.3 USER READINESS & IMPACT ASSESSMENT 97
5.16.3.1 User readiness 97
5.16.3.1.1 User A: Hospitals 97
5.16.3.1.2 User B: Ambulatory surgery centers 97
5.16.3.2 Impact assessment 98
5.16.3.2.1 User A: Hospitals 98
5.16.3.2.2 User B: Ambulatory surgery centers 98
5.16.4 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS 99
5.16.5 REGULATORY ANALYSIS 103
6 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 107
6.1 INTRODUCTION 107
6.2 DECISION-MAKING PROCESS 107
6.3 KEY STAKEHOLDERS AND BUYING CRITERIA 108
6.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 108
6.3.2 BUYING CRITERIA 109
6.4 END USER ANALYSIS 109
6.4.1 UNMET NEEDS 109
6.4.2 END USER EXPECTATIONS 110
6.5 ADOPTION BARRIERS & INTERNAL CHALLENGES 111
6.6 MARKET PROFITABILITY 111
?
7 REMOTE PATIENT MONITORING MARKET, BY COMPONENT 112
7.1 INTRODUCTION 113
7.2 DEVICES 113
7.2.1 BY FUNCTION 114
7.2.1.1 Cardiac monitoring devices 115
7.2.1.1.1 Increasing uptake of ECG monitors and rising cases of hypertension to fuel market 115
7.2.1.2 Neurological monitoring devices 116
7.2.1.2.1 Growing demand for clinical-grade wearable devices for routine monitoring to drive market 116
7.2.1.3 Respiratory monitoring devices 117
7.2.1.3.1 Rising demand for peak flow meters and sleep apnea monitors to fuel market 117
7.2.1.4 Blood glucose monitoring devices 118
7.2.1.4.1 Increasing prevalence of diabetes to support market growth 118
7.2.1.5 Fetal & neonatal monitoring devices 119
7.2.1.5.1 Growing focus on vital health monitoring in preterm births to drive market 119
7.2.1.6 Weight monitoring devices 120
7.2.1.6.1 High incidence of obesity and growing advancements in smart weighing scales to fuel market 120
7.2.1.7 Multiparameter monitoring devices 121
7.2.1.7.1 Measurement of spO2, blood sugar, and respiratory activity to fuel uptake 121
7.2.1.8 Pulse oximeter devices 122
7.2.1.8.1 Rising demand in preoperative & home care settings to support market growth 122
7.2.1.9 Thermometers 123
7.2.1.9.1 Growing focus on home healthcare to fuel market 123
7.2.1.10 Other monitoring devices 124
7.2.2 BY TYPE 125
7.2.2.1 Wearable devices 125
7.2.2.1.1 Ability to provide real-time insights to drive market 125
7.2.2.2 Implantable devices 126
7.2.2.2.1 Advancements in wireless communication technologies to boost demand 126
7.2.2.3 Handheld & portable devices 127
7.2.2.3.1 Growing focus on device miniaturization to fuel market 127
7.2.2.4 Other devices 128
7.3 SOFTWARE 129
7.3.1 SOFTWARE, BY DEPLOYMENT MODEL 130
7.3.1.1 On-premises 130
7.3.1.1.1 Enhanced control, data security, and customization benefits to fuel market 130
7.3.1.2 Cloud-based models 131
7.3.1.2.1 Real-time data sharing and high-security features to boost demand 131
7.3.2 SOFTWARE, BY TRANSMISSION TYPE 132
7.3.2.1 Synchronous transmission 133
7.3.2.1.1 Growing availability of real-time data analytics to boost demand 133
7.3.2.2 Asynchronous transmission 133
7.3.2.2.1 Increasing need for low-resource flexible solutions to support market growth 133
7.4 SERVICES 134
7.4.1 EXPANSION OF TELEMEDICINE PLATFORMS AND INTEGRATION OF SERVICE MODELS TO SUPPORT MARKET GROWTH 134
8 REMOTE PATIENT MONITORING MARKET, BY INDICATION 135
8.1 INTRODUCTION 136
8.2 ONCOLOGY 136
8.2.1 GROWING FOCUS ON EARLY DISEASE DETECTION TO DRIVE MARKET 136
8.3 CARDIOLOGY 137
8.3.1 HIGH INCIDENCE OF CVD TO PROPEL MARKET 137
8.4 NEUROLOGY 138
8.4.1 INCREASING PREVALENCE OF NEUROLOGICAL CONDITIONS TO FUEL MARKET 138
8.5 DIABETES 139
8.5.1 GROWING FOCUS ON TELEHEALTH CONSULTATIONS FOR DIABETES MANAGEMENT TO BOOST DEMAND 139
8.6 SLEEP DISORDERS 140
8.6.1 INCREASING INCIDENCE OF SLEEP APNEA TO SUPPORT MARKET GROWTH 140
8.7 RESPIRATORY DISEASES 141
8.7.1 RISING CASES OF COPD AND ASTHMA TO FUEL MARKET 141
8.8 WELLNESS IMPROVEMENT 142
8.8.1 UTILIZATION OF WEIGHT MANAGEMENT & PERSONAL HEALTH APPS TO SUPPORT MARKET GROWTH 142
8.9 MENTAL HEALTH 143
8.9.1 GROWING FOCUS ON DEVELOPMENT OF PREDICTIVE HEALTH MODELS FOR COGNITIVE THERAPY TO PROPEL MARKET 143
8.10 OTHER INDICATIONS 144
9 REMOTE PATIENT MONITORING MARKET, BY END USER 146
9.1 INTRODUCTION 147
9.2 HEALTHCARE PROVIDERS 147
9.2.1 HOSPITALS 148
9.2.1.1 Ability to purchase technologically advanced telehealth devices to fuel market 148
?
9.2.2 ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS 149
9.2.2.1 Increasing demand for cost-effective perioperative devices to fuel market 149
9.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES 150
9.2.3.1 Expanding geriatric population and growing focus on chronic disease management to fuel market 150
9.2.4 HOME HEALTHCARE 151
9.2.4.1 Growing preference for remote care to drive market 151
9.2.5 OTHER HEALTHCARE PROVIDERS 152
9.3 HEALTHCARE PAYERS 153
9.3.1 LOW COSTS AND IMPROVED HEALTHCARE FACILITIES TO DRIVE MARKET 153
9.4 PATIENTS 154
9.4.1 INCREASING FOCUS ON AI INTEGRATION INTO WEARABLE DEVICES TO BOOST DEMAND 154
9.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 155
9.5.1 RISING NEED FOR ENHANCED CLINICAL TRIAL OUTCOMES TO SUPPORT MARKET GROWTH 155
9.6 MEDTECH COMPANIES 155
9.6.1 INTEGRATION OF RPM WITH MEDTECH SOLUTIONS FOR DIAGNOSTIC ACCURACY TO FUEL MARKET 155
9.7 OTHER END USERS 156
10 REMOTE PATIENT MONITORING MARKET, BY REGION 158
10.1 INTRODUCTION 159
10.2 NORTH AMERICA 159
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 160
10.2.2 US 164
10.2.2.1 Supportive regulatory frameworks for AI implementation to boost demand 164
10.2.3 CANADA 168
10.2.3.1 Growing need to curtail healthcare costs to drive market 168
10.3 EUROPE 172
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 172
10.3.2 GERMANY 176
10.3.2.1 Favorable reimbursements for technological innovation to propel market 176
10.3.3 UK 180
10.3.3.1 Government support for AI implementation to boost demand 180
10.3.4 FRANCE 184
10.3.4.1 Implementation of ETAPES program to fuel market 184
10.3.5 ITALY 188
10.3.5.1 Growing focus on digital transformation for value-centric patient care to drive market 188
?
10.3.6 SPAIN 192
10.3.6.1 Rising funding investments for digital health plans to boost market 192
10.3.7 REST OF EUROPE 196
10.4 ASIA PACIFIC 200
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 200
10.4.2 CHINA 205
10.4.2.1 Shortage of physicians and growing focus on RPM solutions to support market growth 205
10.4.3 JAPAN 209
10.4.3.1 Rising geriatric population and subsequent rise in preventive care to drive market 209
10.4.4 INDIA 213
10.4.4.1 Expanding target patient population to drive market 213
10.4.5 AUSTRALIA 217
10.4.5.1 Growing government support and telehealth expansion to drive market 217
10.4.6 SOUTH KOREA 221
10.4.6.1 Strategic partnerships and AI innovations accelerate RPM adoption 221
10.4.7 REST OF ASIA PACIFIC 225
10.5 LATIN AMERICA 229
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 229
10.5.2 BRAZIL 233
10.5.2.1 Growing focus on telehealth consultations to drive market 233
10.5.3 MEXICO 237
10.5.3.1 Improvements in healthcare infrastructure to boost demand 237
10.5.4 REST OF LATIN AMERICA 241
10.6 MIDDLE EAST & AFRICA 245
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 246
10.6.2 GCC 249
10.6.2.1 Government initiatives for investments in RPM solutions to support market growth 249
10.6.3 SAUDI ARABIA 253
10.6.3.1 Expansion of connected healthcare ecosystem 253
10.6.4 UAE 257
10.6.4.1 Strengthening of connected healthcare ecosystem with AI-enabled RPM solutions to boost market 257
10.6.5 REST OF GCC 261
10.6.5.1 Market propelled by digital health transformation 261
10.6.6 SOUTH AFRICA 265
10.6.6.1 Increasing adoption of telehealth infrastructure to drive market 265
10.6.7 REST OF MIDDLE EAST & AFRICA 269
?
11 COMPETITIVE LANDSCAPE 273
11.1 OVERVIEW 273
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 273
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET 273
11.3 REVENUE ANALYSIS, 2021?2025 275
11.4 MARKET SHARE ANALYSIS, 2025 276
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 279
11.5.1 STARS 279
11.5.2 EMERGING LEADERS 279
11.5.3 PERVASIVE PLAYERS 280
11.5.4 PARTICIPANTS 280
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 281
11.5.5.1 Company footprint 281
11.5.5.2 Region footprint 282
11.5.5.3 Component footprint 283
11.5.5.4 Indication footprint 284
11.5.5.5 End user footprint 285
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 286
11.6.1 PROGRESSIVE COMPANIES 286
11.6.2 RESPONSIVE COMPANIES 286
11.6.3 DYNAMIC COMPANIES 286
11.6.4 STARTING BLOCKS 286
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 287
11.6.5.1 Detailed list of key startups/SMEs 287
11.6.5.2 Competitive benchmarking of startups/SMEs 288
11.7 COMPANY VALUATION & FINANCIAL METRICS 288
11.7.1 FINANCIAL METRICS 288
11.7.2 COMPANY VALUATION 289
11.8 BRAND/SOFTWARE COMPARISON 290
11.9 COMPETITIVE SCENARIO 291
11.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 291
11.9.2 DEALS 292
11.9.3 EXPANSIONS 293
11.9.4 OTHER DEVELOPMENTS 293
?
12 COMPANY PROFILES 294
12.1 KEY PLAYERS 294
12.1.1 KONINKLIJKE PHILIPS N.V. 294
12.1.1.1 Business overview 294
12.1.1.2 Products/Services offered 295
12.1.1.3 Recent developments 297
12.1.1.3.1 Product/Service launches & approvals 297
12.1.1.3.2 Deals 298
12.1.1.4 MnM view 299
12.1.1.4.1 Key strengths 299
12.1.1.4.2 Strategic choices 299
12.1.1.4.3 Weaknesses & competitive threats 300
12.1.2 OMRON HEALTHCARE, INC. (SUBSIDIARY OF OMRON CORPORATION) 300
12.1.2.1 Business overview 300
12.1.2.2 Products/Services offered 301
12.1.2.3 Recent developments 302
12.1.2.3.1 Product/Service launches & approvals 302
12.1.2.3.2 Deals 303
12.1.2.3.3 Other developments 303
12.1.2.4 MnM view 304
12.1.2.4.1 Key strengths 304
12.1.2.4.2 Strategic choices 304
12.1.2.4.3 Weaknesses & competitive threats 304
12.1.3 MEDTRONIC 305
12.1.3.1 Business overview 305
12.1.3.2 Products/Services offered 306
12.1.3.3 Recent developments 308
12.1.3.3.1 Product/Service launches & approvals 308
12.1.3.3.2 Deals 308
12.1.3.3.3 Other developments 309
12.1.3.4 MnM view 310
12.1.3.4.1 Key strengths 310
12.1.3.4.2 Strategic choices 310
12.1.3.4.3 Weaknesses & competitive threats 310
12.1.4 GE HEALTHCARE 311
12.1.4.1 Business overview 311
12.1.4.2 Products/Services offered 312
12.1.4.3 Recent developments 313
12.1.4.3.1 Product/Service launches & approvals 313
12.1.4.3.2 Deals 314
?
12.1.4.4 MnM view 315
12.1.4.4.1 Key strengths 315
12.1.4.4.2 Strategic choices 315
12.1.4.4.3 Weaknesses & competitive threats 315
12.1.5 ABBOTT 316
12.1.5.1 Business overview 316
12.1.5.2 Products/Services offered 317
12.1.5.3 Recent developments 318
12.1.5.3.1 Product/Service launches & approvals 318
12.1.5.3.2 Expansions 319
12.1.5.3.3 Other developments 319
12.1.5.4 MnM view 319
12.1.5.4.1 Key strengths 319
12.1.5.4.2 Strategic choices 320
12.1.5.4.3 Weaknesses & competitive threats 320
12.1.6 ORACLE 321
12.1.6.1 Business overview 321
12.1.6.2 Products/Services offered 322
12.1.6.3 Recent developments 323
12.1.6.3.1 Product/Service launches & approvals 323
12.1.6.3.2 Deals 323
12.1.7 BOSTON SCIENTIFIC CORPORATION 324
12.1.7.1 Business overview 324
12.1.7.2 Products/Services offered 325
12.1.7.3 Recent developments 326
12.1.7.3.1 Product/Service launches & approvals 326
12.1.7.3.2 Deals 327
12.1.7.3.3 Other developments 327
12.1.8 NIHON KOHDEN CORPORATION 328
12.1.8.1 Business overview 328
12.1.8.2 Products/Services offered 329
12.1.8.3 Recent developments 330
12.1.8.3.1 Product/Service launches & approvals 330
12.1.8.3.2 Deals 331
12.1.9 SIEMENS HEALTHINEERS AG 332
12.1.9.1 Business overview 332
12.1.9.2 Products/Services offered 333
12.1.9.3 Recent developments 334
12.1.9.3.1 Product/Service launches & approvals 334
12.1.9.3.2 Deals 334
?
12.1.10 BAXTER 335
12.1.10.1 Business overview 335
12.1.10.2 Products/Services offered 336
12.1.10.3 Recent developments 337
12.1.10.3.1 Product/Service launches & approvals 337
12.1.10.3.2 Deals 337
12.1.11 BIOBEAT 338
12.1.11.1 Business overview 338
12.1.11.2 Products/Services offered 338
12.1.11.3 Recent developments 338
12.1.11.3.1 Product/Service launches & approvals 338
12.1.11.3.2 Deals 339
12.1.12 BIOTRONIK 341
12.1.12.1 Business overview 341
12.1.12.2 Products/Services offered 341
12.1.12.3 Recent developments 342
12.1.12.3.1 Product/Service launches & approvals 342
12.1.12.3.2 Deals 343
12.1.13 VITALCONNECT 344
12.1.13.1 Business overview 344
12.1.13.2 Products/Services offered 344
12.1.13.3 Recent developments 345
12.1.13.3.1 Deals 345
12.1.13.3.2 Other developments 345
12.1.14 VIVALNK, INC. 346
12.1.14.1 Business overview 346
12.1.14.2 Products/Services offered 346
12.1.14.3 Recent developments 347
12.1.14.3.1 Product/Service launches & approvals 347
12.1.14.3.2 Deals 347
12.1.15 CLEARARCH, INC. 348
12.1.15.1 Business overview 348
12.1.15.2 Products/Services offered 348
12.1.15.3 Recent developments 349
12.1.15.3.1 Product/Service launches & approvals 349
12.1.15.3.2 Deals 349
12.1.16 OPTUM, INC. (VIVIFY HEALTH ? PART OF OPTUM) 350
12.1.16.1 Business overview 350
12.1.16.2 Products/Services offered 351
?
12.1.17 BLUE SPARK TECHNOLOGIES, INC. 352
12.1.17.1 Business overview 352
12.1.17.2 Products/Services offered 352
12.1.17.3 Recent developments 353
12.1.17.3.1 Product/Service launches & approvals 353
12.1.18 LIGHTBEAM 354
12.1.18.1 Business overview 354
12.1.18.2 Products/Services offered 354
12.1.18.3 Recent developments 355
12.1.18.3.1 Deals 355
12.1.19 CLOUD DIAGNOSTICS CANADA ULC 356
12.1.19.1 Business overview 356
12.1.19.2 Products/Services offered 356
12.1.19.3 Recent developments 357
12.1.19.3.1 Product/Service launches & approvals 357
12.1.19.3.2 Deals 357
12.1.20 TELADOC HEALTH, INC. 358
12.1.20.1 Business overview 358
12.1.20.2 Products/Services offered 359
12.1.20.3 Recent developments 360
12.1.20.3.1 Product/Service launches & approvals 360
12.1.20.3.2 Deals 360
12.1.21 GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD. 361
12.1.21.1 Business overview 361
12.1.21.2 Products/Services offered 361
12.1.21.3 Recent developments 362
12.1.21.3.1 Other developments 362
12.2 OTHER PLAYERS 363
12.2.1 CARESIMPLE INC. 363
12.2.2 TIMEDOC, INC. 364
12.2.3 COACHCARE 365
12.2.4 DOZEE (TURTLE SHELL TECHNOLOGIES PVT LTD) 366
12.2.5 HEALTH RECOVERY SOLUTIONS 366
13 RESEARCH METHODOLOGY 367
13.1 RESEARCH DATA 367
13.1.1 SECONDARY DATA 368
13.1.1.1 Key data from secondary sources 368
13.1.2 PRIMARY DATA 369
13.1.2.1 Key data from primary sources 370
13.1.2.2 Breakdown of primary sources 371
?
13.2 MARKET SIZE ESTIMATION 372
13.2.1 SUPPLY-SIDE ANALYSIS 373
13.2.2 BOTTOM-UP APPROACH: END USER ADOPTION 375
13.2.3 TOP-DOWN OF PARENT MARKET ASSESSMENT 376
13.2.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 376
13.3 MARKET BREAKDOWN AND DATA TRIANGULATION 380
13.4 RESEARCH ASSUMPTIONS 381
13.4.1 MARKET SIZING ASSUMPTIONS 381
13.4.2 OVERALL STUDY ASSUMPTIONS 381
13.5 RISK ASSESSMENT 382
13.6 RESEARCH LIMITATIONS 382
13.6.1 METHODOLOGY-RELATED LIMITATIONS 382
13.6.2 SCOPE-RELATED LIMITATIONS 382
14 APPENDIX 383
14.1 DISCUSSION GUIDE 383
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 388
14.3 CUSTOMIZATION OPTIONS 390
14.4 RELATED REPORTS 390
14.5 AUTHOR DETAILS 391

ページTOPに戻る

List of Tables/Graphs

TABLE 1 USD EXCHANGE RATES 39
TABLE 2 RECENT DEVELOPMENTS OF AI IN REMOTE PATIENT MONITORING MARKET, JANUARY 2022?DECEMBER 2024 59
TABLE 3 TOP FIVE HEALTHCARE ORGANIZATIONS IMPACTED BY SECURITY BREACHES 63
TABLE 4 REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS 67
TABLE 5 INDICATIVE PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER (2025) 72
TABLE 6 INDICATIVE PRICE OF REMOTE PATIENT MONITORING DEVICES, BY REGION,
2025 (USD) 73
TABLE 7 US ADJUSTED RECIPROCAL TARIFF RATES 82
TABLE 8 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING 90
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 12 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 13 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103
TABLE 14 NORTH AMERICA: REGULATORY ANALYSIS 103
TABLE 15 EUROPE: REGULATORY ANALYSIS 104
TABLE 16 ASIA PACIFIC: REGULATORY ANALYSIS 105
TABLE 17 MIDDLE EAST & AFRICA: REGULATORY ANALYSIS 106
TABLE 18 LATIN AMERICA: REGULATORY ANALYSIS 106
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING, BY END USER 108
TABLE 20 KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING 109
TABLE 21 UNMET NEEDS IN REMOTE PATIENT MONITORING MARKET 110
TABLE 22 END USER EXPECTATIONS IN REMOTE PATIENT MONITORING MARKET 110
TABLE 23 REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 113
TABLE 24 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY REGION,
2024?2031 (USD MILLION) 114
TABLE 25 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION,
2024?2031 (USD MILLION) 114
TABLE 26 CARDIAC MONITORING DEVICES: REMOTE PATIENT MONITORING MARKET,
BY REGION, 2024?2031 (USD MILLION) 115
TABLE 27 NEUROLOGICAL MONITORING DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024?2031 (USD MILLION) 116
TABLE 28 RESPIRATORY MONITORING DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024?2031 (USD MILLION) 118
TABLE 29 BLOOD GLUCOSE MONITORING DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024?2031 (USD MILLION) 119
TABLE 30 FETAL & NEONATAL MONITORING DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024?2031 (USD MILLION) 120
TABLE 31 WEIGHT MONITORING DEVICES: REMOTE PATIENT MONITORING MARKET,
BY REGION, 2024?2031 (USD MILLION) 121
TABLE 32 MULTIPARAMETER MONITORING DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024?2031 (USD MILLION) 122
TABLE 33 PULSE OXIMETER DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024?2031 (USD MILLION) 123
TABLE 34 THERMOMETERS: REMOTE PATIENT MONITORING MARKET, BY REGION,
2024?2031 (USD MILLION) 124
TABLE 35 OTHER MONITORING DEVICES: REMOTE PATIENT MONITORING MARKET,
BY REGION, 2024?2031 (USD MILLION) 124
TABLE 36 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,
2024?2031 (USD MILLION) 125
TABLE 37 WEARABLE DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024?2031 (USD MILLION) 126
TABLE 38 IMPLANTABLE DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024?2031 (USD MILLION) 127
TABLE 39 HANDHELD & PORTABLE DEVICES: REMOTE PATIENT MONITORING MARKET,
BY REGION, 2024?2031 (USD MILLION) 128
TABLE 40 OTHER DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION,
2024?2031 (USD MILLION) 129
TABLE 41 REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY REGION,
2024?2031 (USD MILLION) 129
TABLE 42 REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 130
TABLE 43 ON-PREMISE MODELS: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024?2031 (USD MILLION) 131
TABLE 44 CLOUD-BASED MODELS: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024?2031 (USD MILLION) 132
TABLE 45 REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 132
TABLE 46 SYNCHRONOUS TRANSMISSION: REMOTE PATIENT MONITORING MARKET,
BY REGION, 2024?2031 (USD MILLION) 133
TABLE 47 ASYNCHRONOUS TRANSMISSION: REMOTE PATIENT MONITORING MARKET,
BY REGION, 2024?2031 (USD MILLION) 134
TABLE 48 REMOTE PATIENT MONITORING MARKET FOR SERVICES, BY REGION,
2024?2031 (USD MILLION) 134
TABLE 49 REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 136
TABLE 50 REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY REGION,
2024?2031 (USD MILLION) 137
TABLE 51 REMOTE PATIENT MONITORING MARKET FOR CARDIOLOGY, BY REGION,
2024?2031 (USD MILLION) 138
TABLE 52 REMOTE PATIENT MONITORING MARKET FOR NEUROLOGY, BY REGION,
2024?2031 (USD MILLION) 139
TABLE 53 REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY REGION,
2024?2031 (USD MILLION) 140
TABLE 54 REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2024?2031 (USD MILLION) 141
TABLE 55 REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY DISEASES,
BY REGION, 2024?2031 (USD MILLION) 142
TABLE 56 REMOTE PATIENT MONITORING MARKET FOR WELLNESS IMPROVEMENT,
BY REGION, 2024?2031 (USD MILLION) 143
TABLE 57 REMOTE PATIENT MONITORING MARKET FOR MENTAL HEALTH, BY REGION, 2024?2031 (USD MILLION) 144
TABLE 58 REMOTE PATIENT MONITORING MARKET FOR OTHER INDICATIONS, BY REGION, 2024?2031 (USD MILLION) 145
TABLE 59 REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 147
TABLE 60 REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 148
TABLE 61 REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,
BY REGION, 2024?2031 (USD MILLION) 148
TABLE 62 REMOTE PATIENT MONITORING MARKET FOR HOSPITALS, BY REGION,
2024?2031 (USD MILLION) 149
TABLE 63 REMOTE PATIENT MONITORING MARKET FOR ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2024?2031 (USD MILLION) 150
TABLE 64 REMOTE PATIENT MONITORING MARKET FOR LONG-TERM CARE & ASSISTED LIVING FACILITIES, BY REGION, 2024?2031 (USD MILLION) 151
TABLE 65 REMOTE PATIENT MONITORING MARKET FOR HOME HEALTHCARE, BY REGION, 2024?2031 (USD MILLION) 152
TABLE 66 REMOTE PATIENT MONITORING MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2024?2031 (USD MILLION) 152
TABLE 67 REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PAYERS, BY REGION, 2024?2031 (USD MILLION) 153
TABLE 68 REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY REGION,
2024?2031 (USD MILLION) 154
TABLE 69 REMOTE PATIENT MONITORING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024?2031 (USD MILLION) 155
TABLE 70 REMOTE PATIENT MONITORING MARKET FOR MEDTECH COMPANIES, BY REGION, 2024?2031 (USD MILLION) 156
TABLE 71 REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2024?2031 (USD MILLION) 157
TABLE 72 REMOTE PATIENT MONITORING MARKET, BY REGION, 2024?2031 (USD MILLION) 159
TABLE 73 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 161
TABLE 74 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES,
BY FUNCTION, 2024?2031 (USD MILLION) 161
TABLE 75 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024?2031 (USD MILLION) 162
TABLE 76 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 162
TABLE 77 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 162
TABLE 78 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 163
TABLE 79 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 163
TABLE 80 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 164
TABLE 81 US: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 165
TABLE 82 US: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION,
2024?2031 (USD MILLION) 166
TABLE 83 US: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,
2024?2031 (USD MILLION) 166
TABLE 84 US: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 167
TABLE 85 US: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY DEPLOYMENT TYPE, 167
TABLE 86 US: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 167
TABLE 87 US: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 168
TABLE 88 US: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024?2031 (USD MILLION) 168
TABLE 89 CANADA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 169
TABLE 90 CANADA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 169
TABLE 91 CANADA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,
2024?2031 (USD MILLION) 170
TABLE 92 CANADA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 170
TABLE 93 CANADA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 170
TABLE 94 CANADA: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 171
TABLE 95 CANADA: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 171
TABLE 96 CANADA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 172
TABLE 97 EUROPE: REMOTE PATIENT MONITORING MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 173
TABLE 98 EUROPE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 173
TABLE 99 EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 174
TABLE 100 EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,
2024?2031 (USD MILLION) 174
TABLE 101 EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 175
TABLE 102 EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 175
TABLE 103 EUROPE: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 175
TABLE 104 EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 176
TABLE 105 EUROPE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 176
TABLE 106 GERMANY: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 177
TABLE 107 GERMANY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 177
TABLE 108 GERMANY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024?2031 (USD MILLION) 178
TABLE 109 GERMANY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 178
TABLE 110 GERMANY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 178
TABLE 111 GERMANY: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 179
TABLE 112 GERMANY: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 179
TABLE 113 GERMANY: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 180
TABLE 114 UK: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 181
TABLE 115 UK: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION,
2024?2031 (USD MILLION) 181
TABLE 116 UK: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,
2024?2031 (USD MILLION) 182
TABLE 117 UK: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 182
TABLE 118 UK: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 182
TABLE 119 UK: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 183
TABLE 120 UK: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 183
TABLE 121 UK: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024?2031 (USD MILLION) 184
TABLE 122 FRANCE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 185
TABLE 123 FRANCE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 185
TABLE 124 FRANCE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,
2024?2031 (USD MILLION) 186
TABLE 125 FRANCE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 186
TABLE 126 FRANCE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 186
TABLE 127 FRANCE: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 187
TABLE 128 FRANCE: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 187
TABLE 129 FRANCE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 188
TABLE 130 ITALY: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 189
TABLE 131 ITALY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 189
TABLE 132 ITALY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,
2024?2031 (USD MILLION) 190
TABLE 133 ITALY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 190
TABLE 134 ITALY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 190
TABLE 135 ITALY: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 191
TABLE 136 ITALY: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 191
TABLE 137 ITALY: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024?2031 (USD MILLION) 192
TABLE 138 SPAIN: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 193
TABLE 139 SPAIN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 193
TABLE 140 SPAIN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,
2024?2031 (USD MILLION) 194
TABLE 141 SPAIN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 194
TABLE 142 SPAIN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 194
TABLE 143 SPAIN: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 195
TABLE 144 SPAIN: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 195
TABLE 145 SPAIN: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024?2031 (USD MILLION) 196
TABLE 146 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 197
TABLE 147 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES,
BY FUNCTION, 2024?2031 (USD MILLION) 197
TABLE 148 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES,
BY TYPE, 2024?2031 (USD MILLION) 198
TABLE 149 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 198
TABLE 150 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 198
TABLE 151 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024?2031 (USD MILLION) 199
TABLE 152 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 199
TABLE 153 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 200
TABLE 154 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 201
TABLE 155 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 202
TABLE 156 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES,
BY FUNCTION, 2024?2031 (USD MILLION) 202
TABLE 157 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024?2031 (USD MILLION) 203
TABLE 158 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 203
TABLE 159 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 203
TABLE 160 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 204
TABLE 161 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 204
TABLE 162 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 205
TABLE 163 CHINA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 206
TABLE 164 CHINA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 206
TABLE 165 CHINA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,
2024?2031 (USD MILLION) 207
TABLE 166 CHINA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 207
TABLE 167 CHINA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 207
TABLE 168 CHINA: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 208
TABLE 169 CHINA: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 208
TABLE 170 CHINA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 209
TABLE 171 JAPAN: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 210
TABLE 172 JAPAN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 210
TABLE 173 JAPAN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,
2024?2031 (USD MILLION) 211
TABLE 174 JAPAN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 211
TABLE 175 JAPAN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 211
TABLE 176 JAPAN: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 212
TABLE 177 JAPAN: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 212
TABLE 178 JAPAN: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024?2031 (USD MILLION) 213
TABLE 179 INDIA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 214
TABLE 180 INDIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 214
TABLE 181 INDIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,
2024?2031 (USD MILLION) 215
TABLE 182 INDIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 215
TABLE 183 INDIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 215
TABLE 184 INDIA: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 216
TABLE 185 INDIA: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 216
TABLE 186 INDIA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024?2031 (USD MILLION) 217
TABLE 187 AUSTRALIA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 218
TABLE 188 AUSTRALIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 218
TABLE 189 AUSTRALIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024?2031 (USD MILLION) 219
TABLE 190 AUSTRALIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 219
TABLE 191 AUSTRALIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 219
TABLE 192 AUSTRALIA: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 220
TABLE 193 AUSTRALIA: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 220
TABLE 194 AUSTRALIA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 221
TABLE 195 SOUTH KOREA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 221
TABLE 196 SOUTH KOREA: REMOTE PATIENT MONITORING MARKET FOR DEVICES,
BY FUNCTION, 2024?2031 (USD MILLION) 222
TABLE 197 SOUTH KOREA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024?2031 (USD MILLION) 222
TABLE 198 SOUTH KOREA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 223
TABLE 199 SOUTH KOREA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 223
TABLE 200 SOUTH KOREA: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 223
TABLE 201 SOUTH KOREA: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 224
TABLE 202 SOUTH KOREA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 224
TABLE 203 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 225
TABLE 204 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES,
BY FUNCTION, 2024?2031 (USD MILLION) 226
TABLE 205 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES,
BY TYPE, 2024?2031 (USD MILLION) 226
TABLE 206 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 227
TABLE 207 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 227
TABLE 208 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024?2031 (USD MILLION) 227
TABLE 209 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024?2031 (USD MILLION) 228
TABLE 210 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 228TABLE 211 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 229
TABLE 212 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 230
TABLE 213 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES,
BY FUNCTION, 2024?2031 (USD MILLION) 230
TABLE 214 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024?2031 (USD MILLION) 231
TABLE 215 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 231
TABLE 216 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 231
TABLE 217 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 232
TABLE 218 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 232
TABLE 219 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 233
TABLE 220 BRAZIL: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 234
TABLE 221 BRAZIL: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 234
TABLE 222 BRAZIL: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,
2024?2031 (USD MILLION) 235
TABLE 223 BRAZIL: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 235
TABLE 224 BRAZIL: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 235
TABLE 225 BRAZIL: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 236
TABLE 226 BRAZIL: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 236
TABLE 227 BRAZIL: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 237
TABLE 228 MEXICO: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 238
TABLE 229 MEXICO: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 238
TABLE 230 MEXICO: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,
2024?2031 (USD MILLION) 239
TABLE 231 MEXICO: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 239
TABLE 232 MEXICO: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 239
TABLE 233 MEXICO: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 240
TABLE 234 MEXICO: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 240
TABLE 235 MEXICO: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 241
TABLE 236 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET,
BY COMPONENT, 2024?2031 (USD MILLION) 242
TABLE 237 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 242
TABLE 238 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024?2031 (USD MILLION) 243
TABLE 239 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 243
TABLE 240 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 243
TABLE 241 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET,
BY INDICATION, 2024?2031 (USD MILLION) 244
TABLE 242 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024?2031 (USD MILLION) 244
TABLE 243 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 245
TABLE 244 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024?2031 (USD MILLION) 246
TABLE 245 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET,
BY COMPONENT, 2024?2031 (USD MILLION) 246
TABLE 246 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 247
TABLE 247 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024?2031 (USD MILLION) 247
TABLE 248 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 248
TABLE 249 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 248
TABLE 250 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024?2031 (USD MILLION) 248
TABLE 251 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024?2031 (USD MILLION) 249
TABLE 252 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 249
TABLE 253 GCC: REMOTE PATIENT MONITORING MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 250
TABLE 254 GCC: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 250
TABLE 255 GCC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 251
TABLE 256 GCC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,
2024?2031 (USD MILLION) 251
TABLE 257 GCC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 252
TABLE 258 GCC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 252
TABLE 259 GCC: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 252
TABLE 260 GCC: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 253
TABLE 261 GCC: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024?2031 (USD MILLION) 253
TABLE 262 SAUDI ARABIA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 254
TABLE 263 SAUDI ARABIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES,
BY FUNCTION, 2024?2031 (USD MILLION) 254
TABLE 264 SAUDI ARABIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024?2031 (USD MILLION) 255
TABLE 265 SAUDI ARABIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 255
TABLE 266 SAUDI ARABIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 255
TABLE 267 SAUDI ARABIA: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 256
TABLE 268 SAUDI ARABIA: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 256
TABLE 269 SAUDI ARABIA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 257
TABLE 270 UAE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 258
TABLE 271 UAE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 258
TABLE 272 UAE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,
2024?2031 (USD MILLION) 259
TABLE 273 UAE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 259
TABLE 274 UAE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 259
TABLE 275 UAE: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 260
TABLE 276 UAE: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 260
TABLE 277 UAE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024?2031 (USD MILLION) 261
TABLE 278 REST OF GCC: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 262
TABLE 279 REST OF GCC: REMOTE PATIENT MONITORING MARKET FOR DEVICES,
BY FUNCTION, 2024?2031 (USD MILLION) 262
TABLE 280 REST OF GCC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024?2031 (USD MILLION) 263
TABLE 281 REST OF GCC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 263
TABLE 282 REST OF GCC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 263
TABLE 283 REST OF GCC: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 264
TABLE 284 REST OF GCC: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 264
TABLE 285 REST OF GCC: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 265
TABLE 286 SOUTH AFRICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 265
TABLE 287 SOUTH AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES,
BY FUNCTION, 2024?2031 (USD MILLION) 266
TABLE 288 SOUTH AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024?2031 (USD MILLION) 266
TABLE 289 SOUTH AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 267
TABLE 290 SOUTH AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,
BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 267
TABLE 291 SOUTH AFRICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024?2031 (USD MILLION) 267
TABLE 292 SOUTH AFRICA: REMOTE PATIENT MONITORING MARKET, BY END USER,
2024?2031 (USD MILLION) 268
TABLE 293 SOUTH AFRICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 268
TABLE 294 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET,
BY COMPONENT, 2024?2031 (USD MILLION) 269
TABLE 295 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024?2031 (USD MILLION) 270
TABLE 296 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024?2031 (USD MILLION) 270
TABLE 297 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024?2031 (USD MILLION) 271
TABLE 298 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024?2031 (USD MILLION) 271
TABLE 299 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET,
BY INDICATION, 2024?2031 (USD MILLION) 271
TABLE 300 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET,
BY END USER, 2024?2031 (USD MILLION) 272
TABLE 301 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 272
TABLE 302 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET, JANUARY 2023?APRIL 2026 273
TABLE 303 REMOTE PATIENT MONITORING MARKET: DEGREE OF COMPETITION 277
TABLE 304 REMOTE PATIENT MONITORING MARKET: REGION FOOTPRINT 282
TABLE 305 REMOTE PATIENT MONITORING MARKET: COMPONENT FOOTPRINT 283
TABLE 306 REMOTE PATIENT MONITORING MARKET: INDICATION FOOTPRINT 284
TABLE 307 REMOTE PATIENT MONITORING MARKET: END USER FOOTPRINT 285
TABLE 308 REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 287
TABLE 309 REMOTE PATIENT MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION 288
TABLE 310 REMOTE PATIENT MONITORING MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023?APRIL 2026 291
TABLE 311 REMOTE PATIENT MONITORING MARKET: DEALS, JANUARY 2023?APRIL 2026 292
TABLE 312 REMOTE PATIENT MONITORING MARKET: EXPANSIONS,
JANUARY 2023?APRIL 2026 293
TABLE 313 REMOTE PATIENT MONITORING MARKET: OTHER DEVELOPMENTS,
JANUARY 2023?APRIL 2026 293
TABLE 314 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 294
TABLE 315 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES OFFERED 295
TABLE 316 KONINKL